Institute of Genetic and Biomedical Research, National Research Council, Cittadella Universitaria Di Cagliari, c/o S.S 554 bivio per Sestu Km 4,500, 09042, Monserrato, Cagliari, Italy.
Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):691-698. doi: 10.1007/s00417-022-05858-5. Epub 2022 Oct 20.
To ascertain the prevalence and clinical and genetic features of age-related macular degeneration (AMD) in subjects living in the Lanusei valley, Central Sardinia, Italy, involved in a study on ageing (SardiNIA project).
A total of 814 volunteers aged ≥ 50 years, randomly selected from the SardiNIA project dataset, were included. A color fundus (CF) photograph of the 30° central retina of each eye was obtained and graded according to the Age-Related Eye Disease Study system. Life-style choices were investigated using standardized questionnaires. The concentrations of several inflammatory biomarkers (i.e., complement component, fibrinogen, and C-reactive protein) were measured. Polygenic risk score (PRS) was calculated and compared with results obtained from a European cohort.
A total of 756 subjects had gradable CF photographs for AMD detection. In 91.3%, no signs of AMD were observed. The prevalence rates of early and late AMDs were 6.9% and 0.6%, respectively. A total of 85% of subjects were physically active; only 13.5% were current smokers. Low concentrations of complement component, fibrinogen, and C-reactive protein were found. We calculated the polygenic risk scores (PRS) using 40 AMD markers distributed on several candidate genes in Europeans and Sardinians. The mean PRS value was significantly lower in Sardinians than in the Europeans (0.21 vs. 0.248, respectively, p = 1.18 × 10).
In our cohort, most subjects showed no sign of any AMD type and late AMD was a condition rarely observed. Results of genetic, biochemical, and life-style investigation support the hypothesis that Sardinia population may present of a peculiar background with a protective effect against AMD development.
确定居住在意大利撒丁岛拉努塞伊山谷的受试者中与年龄相关的黄斑变性(AMD)的患病率以及临床和遗传特征,这些受试者参与了一项关于衰老的研究(SardiNIA 项目)。
从 SardiNIA 项目数据集中随机选择了 814 名年龄≥50 岁的志愿者。获取每只眼 30°中央视网膜的彩色眼底(CF)照片,并根据年龄相关性眼病研究系统进行分级。使用标准化问卷调查生活方式选择。测量几种炎症生物标志物(即补体成分、纤维蛋白原和 C 反应蛋白)的浓度。计算多基因风险评分(PRS)并与来自欧洲队列的结果进行比较。
共有 756 名受试者有可分级的 CF 照片用于 AMD 检测。在 91.3%的患者中,未观察到 AMD 的迹象。早期和晚期 AMD 的患病率分别为 6.9%和 0.6%。85%的受试者身体活跃;只有 13.5%的人是当前吸烟者。发现补体成分、纤维蛋白原和 C 反应蛋白的浓度较低。我们使用分布在欧洲人和撒丁岛人几个候选基因上的 40 个 AMD 标志物计算多基因风险评分(PRS)。撒丁岛人的平均 PRS 值明显低于欧洲人(分别为 0.21 和 0.248,p=1.18×10)。
在我们的队列中,大多数受试者没有任何 AMD 类型的迹象,晚期 AMD 是一种罕见的情况。遗传、生化和生活方式调查的结果支持这样一种假设,即撒丁岛人群可能具有一种特殊的背景,对 AMD 的发展具有保护作用。